Dantrium (Dantrolene Injection) and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Dantrium (Dantrolene Injection) and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dantrolene
Brand name: Dantrium, Dantrium Intravenous, Revonto, Ryanodex
Synonyms: Dantrium
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dantrium (Dantrolene Injection)-Moxifloxacin
- Dantrium (Dantrolene Injection)-Moxifloxacin (Systemic)
- Dantrium (Dantrolene Injection)-Moxifloxacin Hydrochloride
- Dantrium (Dantrolene Injection)-Moxifloxacin Injection
- Dantrium (Dantrolene Injection)-Moxifloxacin Intravenous
- Dantrium (Dantrolene Injection)-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Dantrium Intravenous
- Moxetumomab pasudotox-tdfk Intravenous-Dantrolene
- Moxetumomab pasudotox-tdfk Intravenous-Dantrolene Capsules
- Moxetumomab pasudotox-tdfk Intravenous-Dantrolene Injection
- Moxetumomab pasudotox-tdfk Intravenous-Dantrolene Intravenous
- Moxetumomab pasudotox-tdfk Intravenous-Dantrolene Sodium